- Filed
- Mar 31, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 28, 2025 | 12.87M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 11.55M sh |
| Capex | FY 2024 · Dec 31, 2023 | $816K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$52.66M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $54.67M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $60.6M |
| Current Assets | FY 2024 · Dec 31, 2023 | $108.51M |
| Total Assets | FY 2024 · Dec 31, 2023 | $123.07M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$4.35 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$4.35 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $37.11M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $7.17M |
| Net Income | FY 2024 · Dec 31, 2023 | −$50.29M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$50.78M |
| Gross Profit | FY 2024 · Dec 31, 2023 | $8.31M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $118.7M |
| Revenue | FY 2024 · Dec 31, 2023 | $127M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $66.45M |